Study Guide: Inflammatory and Rheumatological Diseases

Inflammatory and Rheumatological Diseases

  • Introduction to Inflammatory and Rheumatological Diseases
      - Focus of next series of lectures.
      - Familiarity due to prior discussions on the immune system.
      - Inflammatory diseases affect multiple body systems.

  • Context of Joint Pain
      - Topic introduced with common patient complaint: "my joints hurt."
      - Various possible diagnoses discussed, but no exhaustive list to be covered.
      - Focus on common diseases, starting with rheumatoid arthritis.

Autoimmune Rheumatic Diseases

  • Definition and Characteristics
      - Autoimmune rheumatic diseases:
        - Group of chronic disorders.
        - Characterized by diffuse inflammatory lesions and degenerative changes.
        - Primarily affect connective tissues leading to pain.

  • Importance of Terminology
      - Familiar terms such as neutrophils and cytokines critical to understanding pathophysiology and etiology.

Rheumatoid Arthritis (RA)

  • Presentation and Symptoms
      - Patient example: presenting symptoms of pain and stiffness, particularly in the morning.
      - Typical symptoms include:
        - Polyarticular pain and swelling.
        - Systemic inflammation leading to:
          - Fatigue.
          - Anorexia.
          - Weight loss.
          - Generalized aching.
          - Localized tenderness.
          - Anemia (anemia of chronic disease).
          - Rheumatoid nodules.
          - Pleuritis and pericarditis.
          - Neuropathy and scleritis.
          - Potential for vasculitis and renal disease.
          - Pattern of exacerbations and remissions, which may involve few joints or progress relentlessly.

  • Diagnostic Criteria
      - Essential for identifying RA:
        - Positive rheumatoid factor (moderately specific).
        - Caution: positive rheumatoid factor does not confirm RA; associated with other conditions (e.g., lupus, infections).
        - Importance of being aware of other factors that may influence positive results.
      - Specific antibodies to measure:
        - Anti-citrullinated protein antibodies (ACPA).
        - Anti-cyclic citrullinated peptide antibodies (CCPs).
      - Importance of additional tests:
        - Erythrocyte sedimentation rate (ESR).
        - C-reactive protein (CRP).
        - Indicators of inflammation; not specific to RA.

Pathophysiology and Etiology of RA

  • Genetic and Environmental Components
      - Polygenic nature of disease; multiple genes contribute.
      - Role of environmental triggers in disease onset.
      - Association with major histocompatibility complex (MHC/HLA) genes.

  • Immune Mechanisms
      - Innate immune system activation leads to joint inflammation.
      - Antigen presenting cells present to the adaptive immune system.
      - Activation of T cells and B cells results in:
        - Release of inflammatory cytokines (tumor necrosis factor, interleukins).
        - Increased antibody production targeting foreign proteins in joints.
        - Breakdown of cartilage and bone, creating thickened synovium (pannus).
        - Involvement of macrophages and the complement system in the inflammatory cascade.

  • Clinical Implications
      - Importance of stopping the inflammatory process promptly.
      - Often, symptoms of systemic disease arise before patient report.
      - Highlighted need for early diagnosis and prompt referral to specialists.

Management of RA

  • Role of Primary Care Providers
      - Educate patients about chronic disease management.
      - Non-pharmacological measures (cognitive behavioral interventions, physical and occupational therapy).
      - Coordination with rheumatologists for medication management (DMARDs, corticosteroids).

  • Monitoring and Follow-Up
      - Regularly check labs for:
        - CBC for anemia.
        - Liver and kidney functions due to medication risks.
        - Eye exams, particularly for patients on immunosuppressive therapy.
      - Importance of interprofessional collaboration to manage comorbidities and monitor for infections.

Complications of RA Treatment

  • Mistakes in Management
      - Risks if medications are not managed appropriately, leading to severe infections.
      - Consideration of halting immunosuppressive drugs in the context of new infections.

Transition to Juvenile Idiopathic Arthritis (JIA)

  • Introduction to JIA
      - Previously known as juvenile rheumatoid arthritis.
      - Similar pathophysiology to adult RA: synovitis, accumulation of synovial fluid, and panus formation.

  • Epidemiology
      - Peak incidence between ages 1-3 years, with a noted increase in girls.
      - Secondary peak in ages 8-10 with higher incidence in boys.
      - Higher prevalence among Caucasians.

  • Clinical Manifestations
      - Symptoms in children include:
        - Fever, arthritis, rashes, lymphadenopathy.
        - Laboratory abnormalities: granulocyte leukocytosis, elevated ESR/CRP, hyperferritinemia.
        - Concerns regarding growth plate damage due to inflammatory processes.

  • Management Approaches
      - Treatment typically involves:
        - Non-steroidal anti-inflammatory drugs (NSAIDs).
        - Glucocorticoids for severe flares.
      - Importance of specialist management for better outcomes.